Ectoine Biosensor Using Transcription Factor EutR
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting and quantifying heterocyclic amino acids like ectoine are limited by low throughput, high cost, and inability to accurately identify non-leaky strains, requiring improved biosensors for high-throughput and low-cost screening in microbial production strains.
Innovation Solution
A biosensor system using a transcription factor-based inducible gene expression system in recombinant host cells, specifically Pseudomonas putida or E. coli, that responds to ectoine by modulating the expression of a reporter gene, allowing for accurate detection and quantification of ectoine concentrations with low background expression and high sensitivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If HPLC analysis is used for ectoine detection and quantification, then measurement precision is improved, but productivity deteriorates due to low throughput and high cost
Solution Approach 1:
The patent replaces the mechanical/chemical HPLC system with a biological biosensor system based on transcription factor-mediated gene expression. The biosensor uses a reporter gene (e.g., GFP) whose expression is regulated by a transcription factor that responds to ectoine, enabling detection through fluorescence measurement instead of complex chromatographic separation, thus achieving high throughput while maintaining accuracy
Solution Approach 2:
The patent creates a simplified copy of the HPLC detection function using a biological system. Instead of physically separating and detecting ectoine molecules through HPLC, the system uses a reporter gene expression copy that reflects ectoine presence and concentration through fluorescence signal, providing a faster and more scalable alternative
2Measurement precision
If HPLC analysis is used for ectoine detection, then measurement precision is improved, but device complexity and cost increase
Solution Approach 1:
The patent extracts the essential detection function from the complex HPLC system. Instead of using complex chromatographic columns, detectors, and sample preparation steps, the biosensor system extracts only the critical function of detecting ectoine presence through a simplified biological response mechanism (transcription factor binding to promoter), dramatically reducing system complexity
Solution Approach 2:
The patent replaces expensive, complex HPLC equipment with a disposable biosensor system based on engineered bacterial cells. The biosensor can be implemented in inexpensive 96-well plates or microtiter plates, allowing high-throughput screening at very low cost per sample compared to HPLC instrument operation and maintenance
3Productivity
If traditional biosensor systems are used, then productivity is improved, but measurement precision deteriorates due to high background expression and leakiness
Solution Approach 1:
The patent changes the regulatory parameters of the biosensor system by using a transcription factor-promoter architecture with specific binding affinity characteristics. The transcription factor binds to the promoter with high specificity only when ectoine is present, creating a switch-like response that minimizes background expression while maintaining high sensitivity for ectoine detection, thus resolving the leakiness problem
4Productivity
If rapid detection methods are implemented, then productivity is improved, but measurement precision deteriorates due to inability to identify non-leaky strains
Solution Approach 1:
The patent incorporates feedback through quantitative fluorescence measurement of the reporter gene expression. The intensity of fluorescence provides a direct readout of transcription factor activation, which correlates with ectoine concentration. This feedback mechanism enables both rapid detection and accurate quantification, allowing differentiation between leaky and non-leaky strains based on the magnitude and kinetics of the fluorescence response
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biosensor system enables sensitive and rapid detection of ectoine with a lower minimal concentration threshold, reducing the need for costly HPLC analysis and improving strain screening efficiency, facilitating the identification of improved production strains.
Implementation Method 1
the transcription factor through the binding to the inducible promoter regulates transcription of the coding region
Implementation Method 2
inducible gene expression system that drives the expression of a reporter gene, wherein when the inducible system is not activated; the expression of the reporter is absent or very low
Implementation Method 3
The inducible system is activated in dose-dependent manner in the presence of ectoine
Data Source
Figure 1A~1B
Figure 2~3B
Figure 4A~6
AI summary
Ectoine-responsive biosensor comprising a recombinant host cell and DNA polynucleotide sequences which encode a transcription factor EutR and inducible promoter operably linked to a coding region, wherein the coding region encodes a reporter gene. The transcription factor through the binding to the inducible promoter regulates transcription of the coding region. The biosensor comprises DNA polynucleotide sequences in a plasmid construct. The use of biosensor comprises a method for detecting ectoine and measuring its concentration.